Edgewise Therapeutics (EWTX) PT Raised to $52 at Truist Securities
May 6, 2026 7:11 AM
Truist Securities analyst Srikripa Devarakonda raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $52.00 (from $46.00) while maintaining a Buy rating.
